Literature DB >> 31102404

Improving Influenza Vaccine Effectiveness: Ways to Begin Solving the Problem.

Arnold S Monto1, Joshua G Petrie1.   

Abstract

Year:  2019        PMID： 31102404     DOI： 10.1093/cid/ciz416

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  8 in total

1.  Review of Analyses Estimating Relative Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Three Consecutive US Influenza Seasons.

Authors:  Constantina Boikos; Ian McGovern; Deborah Molrine; Justin R Ortiz; Joan Puig-Barberà; Mendel Haag
Journal:  Vaccines (Basel)       Date:  2022-06-03

2.  Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 Season.

Authors:  Brendan Flannery; Rebecca J Garten Kondor; Jessie R Chung; Manjusha Gaglani; Michael Reis; Richard K Zimmerman; Mary Patricia Nowalk; Michael L Jackson; Lisa A Jackson; Arnold S Monto; Emily T Martin; Edward A Belongia; Huong Q McLean; Sara S Kim; Lenee Blanton; Krista Kniss; Alicia P Budd; Lynnette Brammer; Thomas J Stark; John R Barnes; David E Wentworth; Alicia M Fry; Manish Patel
Journal:  J Infect Dis       Date:  2020-01-01       Impact factor: 5.226

3.  Vaccine Effectiveness Against Influenza-Associated Hospitalizations Among Adults, 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network.

Authors:  Jill M Ferdinands; Manjusha Gaglani; Shekhar Ghamande; Emily T Martin; Donald Middleton; Arnold S Monto; Fernanda Silveira; Helen K Talbot; Richard Zimmerman; Emily R Smith; Manish Patel
Journal:  J Infect Dis       Date:  2021-07-02       Impact factor: 5.226

4.  Relative Effectiveness of the Cell-derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-related Medical Encounters During the 2018-2019 Influenza Season in the United States.

Authors:  Constantina Boikos; Lauren Fischer; Dan O'Brien; Joe Vasey; Gregg C Sylvester; James A Mansi
Journal:  Clin Infect Dis       Date:  2021-08-02       Impact factor: 9.079

5.  MADE: A Computational Tool for Predicting Vaccine Effectiveness for the Influenza A(H3N2) Virus Adapted to Embryonated Eggs.

Authors:  Hui Chen; Junqiu Wang; Yunsong Liu; Ivy Quek Ee Ling; Chih Chuan Shih; Dafei Wu; Zhiyan Fu; Raphael Tze Chuen Lee; Miao Xu; Vincent T Chow; Sebastian Maurer-Stroh; Da Zhou; Jianjun Liu; Weiwei Zhai
Journal:  Vaccines (Basel)       Date:  2022-06-06

6.  Coronavirus disease 2019 (COVID-19) Versus Influenza in Hospitalized Adult Patients in the United States: Differences in Demographic and Severity Indicators.

Authors:  H Keipp Talbot; Emily T Martin; Manjusha Gaglani; Donald B Middleton; Shekhar Ghamande; Fernanda P Silveira; Kempapura Murthy; Richard K Zimmerman; Christopher H Trabue; Samantha M Olson; Joshua G Petrie; Jill M Ferdinands; Manish M Patel; Arnold S Monto
Journal:  Clin Infect Dis       Date:  2021-12-16       Impact factor: 9.079

7.  Effects of Influenza Vaccination in the United States During the 2018-2019 Influenza Season.

Authors:  Jessie R Chung; Melissa A Rolfes; Brendan Flannery; Pragati Prasad; Alissa O'Halloran; Shikha Garg; Alicia M Fry; James A Singleton; Manish Patel; Carrie Reed
Journal:  Clin Infect Dis       Date:  2020-11-05       Impact factor: 20.999

8.  Effectiveness of the Cell-Derived Inactivated Quadrivalent Influenza Vaccine in Individuals at High Risk of Influenza Complications in the 2018-2019 United States Influenza Season.

Authors:  Constantina Boikos; Mahrukh Imran; Van Hung Nguyen; Thierry Ducruet; Gregg C Sylvester; James A Mansi
Journal:  Open Forum Infect Dis       Date:  2021-04-02       Impact factor: 3.835
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.